[Plasma-cAMP in primary and secondary hyperparathyroidism (author's transl)]. 1976

P Endres, and J Happ, and H Köhler, and P Fiegel

3 patients with operatively proven primary hyperparathyroidism showed normal plasma cAMP concentrations. 5 patients in chronic dialysis treatment independent of the level of parathyroid hormone had increased plasma cAMP concentrations. These observations suggest that there is under these circumstances no regulation of plasma cAMP by the parathyroid hormone.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

P Endres, and J Happ, and H Köhler, and P Fiegel
June 1980, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
P Endres, and J Happ, and H Köhler, and P Fiegel
April 1981, Revue medicale de Bruxelles,
P Endres, and J Happ, and H Köhler, and P Fiegel
May 1979, Deutsche medizinische Wochenschrift (1946),
P Endres, and J Happ, and H Köhler, and P Fiegel
November 1978, Revista medica de Chile,
P Endres, and J Happ, and H Köhler, and P Fiegel
January 1980, Casopis lekaru ceskych,
P Endres, and J Happ, and H Köhler, and P Fiegel
January 1974, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
P Endres, and J Happ, and H Köhler, and P Fiegel
May 1974, Deutsche medizinische Wochenschrift (1946),
P Endres, and J Happ, and H Köhler, and P Fiegel
March 1971, Israel journal of medical sciences,
P Endres, and J Happ, and H Köhler, and P Fiegel
December 1976, Langenbecks Archiv fur Chirurgie,
P Endres, and J Happ, and H Köhler, and P Fiegel
June 1977, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!